As of 2025-10-14, the Intrinsic Value of Tenet Healthcare Corp (THC) is 704.41 USD. This THC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 190.00 USD, the upside of Tenet Healthcare Corp is 270.70%.
The range of the Intrinsic Value is 577.69 - 895.00 USD
Based on its market price of 190.00 USD and our intrinsic valuation, Tenet Healthcare Corp (THC) is undervalued by 270.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 577.69 - 895.00 | 704.41 | 270.7% |
| DCF (Growth 10y) | 658.85 - 985.36 | 789.86 | 315.7% |
| DCF (EBITDA 5y) | 475.16 - 656.43 | 529.27 | 178.6% |
| DCF (EBITDA 10y) | 580.73 - 785.61 | 649.16 | 241.7% |
| Fair Value | 419.92 - 419.92 | 419.92 | 121.01% |
| P/E | 261.02 - 789.21 | 515.81 | 171.5% |
| EV/EBITDA | 229.84 - 610.05 | 358.86 | 88.9% |
| EPV | 698.55 - 918.12 | 808.34 | 325.4% |
| DDM - Stable | 108.18 - 210.93 | 159.56 | -16.0% |
| DDM - Multi | 322.90 - 506.58 | 395.71 | 108.3% |
| Market Cap (mil) | 16,786.50 |
| Beta | 0.87 |
| Outstanding shares (mil) | 88.35 |
| Enterprise Value (mil) | 27,336.50 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.52% |
| Cost of Debt | 5.40% |
| WACC | 7.20% |